Exane Derivatives’s Broadcom AVGO Stock Holding History

Exane Derivatives’s Portfolio AVGO Stock Details AVGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$205K	Sell	4,210 -23,900	-85%	-$1.34M	0.12%	162
2022 Q1	$1.77M	Sell	28,110 -5,510	-16%	-$327K	0.5%	42
2021 Q4	$2.24M	Buy	33,620 +3,880	+13%	+$218K	0.54%	31
2021 Q3	$1.44M	Buy	29,740 +3,130	+12%	+$152K	0.35%	63
2021 Q2	$1.29M	Buy	26,610 +25,790	+3,145%	+$1.2M	0.29%	76
2021 Q1	$38K	Sell	820 -12,160	-94%	-$562K	0.01%	537
2020 Q4	$568K	Buy	12,980 +8,340	+180%	+$325K	0.17%	127
2020 Q3	$169K	Sell	4,640 -32,800	-88%	-$1.1M	0.05%	223
2020 Q2	$1.18M	Sell	37,440 -3,190	-8%	-$89.3K	0.32%	83
2020 Q1	$963K	Buy	40,630 +22,000	+118%	+$620K	0.27%	81
2019 Q4	$565K	Buy	18,630 +8,790	+89%	+$267K	0.1%	158
2019 Q3	$272K	Buy	9,840 +6,020	+158%	+$171K	0.05%	207
2019 Q2	$110K	Sell	3,820 -20,980	-85%	-$611K	0.02%	322
2019 Q1	$745K	Sell	24,800 -166,170	-87%	-$4.51M	0.15%	132
2018 Q4	$4.85M	Buy	190,970 +185,870	+3,645%	+$4.39M	0.87%	19
2018 Q3	$126K	Buy	5,100 +1,070	+27%	+$24K	0.02%	294
2018 Q2	$97.7K	Sell	4,030 -54,360	-93%	-$1.33M	0.02%	335
2018 Q1	$1.38M	Buy	58,390 +50,540	+644%	+$1.27M	0.28%	88
2017 Q4	$202K	Sell	7,850 -68,220	-90%	-$1.77M	0.03%	237
2017 Q3	$1.84M	Sell	76,070 -9,120	-11%	-$225K	0.34%	49
2017 Q2	$1.98M	Sell	85,190 -41,750	-33%	-$969K	0.43%	64
2017 Q1	$2.78M	Sell	126,940 -114,110	-47%	-$2.35M	0.63%	50
2016 Q4	$4.26M	Sell	241,050 -239,820	-50%	-$4.15M	0.84%	20
2016 Q3	$8.3M	Buy	480,870 +475,550	+8,939%	+$7.95M	1.24%	19
2016 Q2	$82.7K	Buy	5,320 +2,580	+94%	+$39.3K	0.01%	249
2016 Q1	$42.3K	Sell	2,740 -2,050	-43%	-$27.7K	0.01%	332
2015 Q4	$69.5K	Buy	4,790 +3,190	+199%	+$41.5K	0.01%	241
2015 Q3	$20K	Sell	1,600 -8,750	-85%	-$111K	﹤0.01%	318
2015 Q2	$138K	Sell	10,350 -1,690,110	-99%	-$22.1M	0.01%	234
2015 Q1	$21.6M	Buy	+1,700,460	New	+$19.5M	2.38%	20

Other funds holding AVGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Exane Derivatives's AVGO Position: Q2 2022 in Review

Exane Derivatives reduced its Broadcom (AVGO) stake by 85% in Q2 2022, selling an estimated $1.34M and leaving 4,210 shares worth $205K. The position accounts for 0.12% of the portfolio, ranked #162.

Exane Derivatives first reported a position in AVGO in Q1 2015 and has held it in 30 quarters since. The position peaked at $21.6M in Q1 2015. 1,998 funds tracked by Wall St. Rank hold AVGO as of Q2 2022.

Exane Derivatives held 4,210 shares of Broadcom worth $205K as of Q2 2022.
Exane Derivatives sold 23,900 Broadcom shares in Q2 2022, an estimated $1.34M.
Broadcom made up 0.12% of Exane Derivatives's portfolio in Q2 2022, its #162 holding.
Exane Derivatives first reported a position in Broadcom in Q1 2015 and has held it in 30 quarters since.
Exane Derivatives's Broadcom position peaked at $21.6M in Q1 2015.
1,998 funds tracked by Wall St. Rank held Broadcom as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.